Search company, investor...

Founded Year

2012

Stage

Series A | Alive

Total Raised

$8.56M

Last Raised

$6.1M | 3 yrs ago

About Single Technologies

Single Technologies develops a new type of single molecule sensitive 3D imaging system to improve research, drug discovery and diagnostics. The technology is a breakthrough approach to screen biomolecules or compounds in live single cells with high throughput.

Headquarters Location

Sankt Eriksgatan 48F

Stockholm, 112 34,

Sweden

+46 (0) 735 280 550

Loading...

Loading...

Single Technologies Patents

Single Technologies has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/27/2015

2/2/2021

Microscopy, Spectroscopy, Microscopes, Cell imaging, Molecular biology

Grant

Application Date

8/27/2015

Grant Date

2/2/2021

Title

Related Topics

Microscopy, Spectroscopy, Microscopes, Cell imaging, Molecular biology

Status

Grant

Latest Single Technologies News

Swedish Sequencing Firm Single Technologies Raises $6.1M

Dec 3, 2020

NEW YORK — Single Technologies said on Thursday that it has raised €5 million ($6.1 million) through an oversubscribed share offering, which it will use to accelerate development of its 3D sequencing platform. The financing included existing investors, as well as new investors Jens von Bahr, Rothesay, Cygnus Montanus Trust, Ulf Landegren, and Andreas Ehn. To read the full story.... Email:

Single Technologies Frequently Asked Questions (FAQ)

  • When was Single Technologies founded?

    Single Technologies was founded in 2012.

  • Where is Single Technologies's headquarters?

    Single Technologies's headquarters is located at Sankt Eriksgatan 48F, Stockholm.

  • What is Single Technologies's latest funding round?

    Single Technologies's latest funding round is Series A.

  • How much did Single Technologies raise?

    Single Technologies raised a total of $8.56M.

  • Who are the investors of Single Technologies?

    Investors of Single Technologies include Andreas Ehn, Rothesay Life, Jens von Bahr, Ulf Landegren, Cygnus Montanus Stiftelse and 5 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.